Skip to content

Second Ejaculate and IUI

Sun Yat-sen Memorial Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05173038
Enrollment
410
Registered
2021-12-29
Start date
2022-05-01
Completion date
2025-12-30
Last updated
2022-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Rate, Sperm Count

Brief summary

The WHO operation specification requires men to maintain a 2-7-day ejaculation abstinence period before semen examination, but it does not mention the possibility of obtaining a second sample immediately after the first sample for evaluation, and the significance of the evaluation of the second sample for fertility. There is a certain fluctuation level in sperm concentration detection. Patients with normal previous detection may have lower sperm concentration on the day of IUI, resulting in the trouble of canceling IUI. It is not clear whether patients with previous oligospermia can obtain more sperm with better vitality and improve the success rate of IUI by taking sperm again. Some retrospective studies found that when the semen abstinence period of oligozoospermia men was as short as 40 minutes, the changes of sperm motility and sperm concentration were significantly improved, but there was no difference in the conclusions of other studies. A small number of assisted reproduction studies found that IUI with samples obtained during abstinence period of less than 2 days could obtain better pregnancy rate. However, the quality and sample size of these retrospective studies are limited, the repeatability is not good enough, and the conclusions are still controversial. We designed a randomized controlled study. Semen examination was performed after sperm extraction. If the sperm concentration after treatment was less than 10m, the subjects were included in the study. They were randomly divided into two groups. Group 1 received IUI for pregnancy assistance directly, and group 2 received IUI for pregnancy assistance 1 hour after the first sperm extraction. The two semen were mixed and treated. 205 subjects were included in the two groups. We tried to explore whether secondary sperm extraction in patients with low IUI concentration can improve the success rate of IUI pregnancy.

Interventions

group patients received IUI for pregnancy assistance 1 hour after the first sperm extraction. The two semen were mixed and treated.

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
22 Years to 80 Years

Inclusion criteria

\- Man 1. Male infertility (primary or secondary infertility) 2. Age 22 \ 80 years old; 3. Body mass index \< 30 kg / m2; 4. Normal levels of FSH, LH, t and PRL; 5. Semen concentration and vitality were normal or slightly abnormal (TSC ≥ 10 million / ml, PR ≥ 20%, vitality ≥ 30%), which was consistent with the indication of IUI assisted pregnancy; 6. On the day of IUI, the male side took the semen and the TSC was less than 10m / ml Women's standard 1. Age 20 \ 40 years old 2. Body mass index \< 30 kg / m2; 3)FSH\<10U/L、AMH\>1.1ng/ml 4\) Bilateral fallopian tubes are unobstructed

Exclusion criteria

* Man It has performed vasectomy, orchitis, unilateral orchiectomy, ejaculation difficulty, retrograde ejaculation, diabetes, cardiovascular disease, drug treatment of psychological or genetic diseases. Woman 1. Previous history of intrauterine adhesion; 2. Hydrosalpinx; 3. B-ultrasound suggests that endometriosis cyst may be;

Design outcomes

Primary

MeasureTime frame
pregnacy rate2021-8-20~2024.12.30

Secondary

MeasureTime frame
semen volume2021-8-20~2024.12.30
forward movement rate2021-8-20~2024.12.30
non forward movement rate2021-8-20~2024.12.30
Semen concentration2021-8-20~2024.12.30
total number of motile sperm after treatment.2021-8-20~2024.12.30
Abortion rate2021-8-20~2024.12.30
proportion of immobile sperm2021-8-20~2024.12.30

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026